Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
In your 30s, reaching wealth-building milestones is crucial. Learn what to aim for to secure your financial future.
19,848 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Kratos Defense stock keeps facing pressure after announcing a sizable stock sale. This guide breaks down dilution, it...
On a day when the market generally slipped, Plug Power captured attention with a solid quarterly report. This piece b...
Is Bloom Energy a buy, sell, or hold in 2026? This guide breaks down the business, potential catalysts, and key risks...
Icahn Enterprises just added a sizable stake in Centuri Holdings, signaling a continued conviction in North America's...
A fresh rally in semiconductor names has investors buzzing about CPU pricing power and AI infrastructure demand. This...
Today’s stock market today faces mixed signals as The Trade Desk slides on a Q1 miss and softer guidance. Here’s what...
Investors tracking UiPath PATH know 2027 will hinge on cloud adoption, service expansion, and pricing power. This gui...
Stride stock has fallen significantly over the last year. This article digs into the reasons behind the decline and e...
A legendary investor speculates SpaceX could reach $30 trillion by 2040. This piece breaks down what that would requi...
Four buyers claim they paid an ex-NBA player for paintings, commissions, and jerseys that never arrived. This caution...
Data centers are growing fast, driven by cloud and AI. The real engine? Utilities expanding power capacity and reliab...